Not All Side Effects Associated With Tricyclic Antidepressant Therapy Are True Side Effects

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 4, 2009, Pages 446-451

  Thiwan, Syed ^a   Drossman, Douglas A ^a   Morris, Carolyn B ^a   Dalton, Chris ^a   Toner, Brenda B ^b   Diamant, Nicholas E ^b   Hu, J B ^a   Whitehead, William E ^a   Leserman, Jane ^a   Bangdiwala, Shrikant I ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DESIPRAMINE; PLACEBO;

ADULT; APPETITE; ARTICLE; BEDTIME DOSAGE; BLURRED VISION; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE SEVERITY; DISTRESS SYNDROME; DIZZINESS; DRUG DOSE INCREASE; DRUG INDUCED DISEASE; ENTEROPATHY; FATIGUE; FEMALE; FLUSHING; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; NERVOUSNESS; QUESTIONNAIRE; RASH; SIDE EFFECT; SLEEP DISORDER; SLURRED SPEECH; SYMPTOM; TREMOR; XEROSTOMIA;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; GASTROINTESTINAL DISEASES; HUMANS; MIDDLE AGED; PLACEBOS; QUESTIONNAIRES;

EID: 62849093933     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.11.014     Document Type: Article

References (19)

1. Drossman D.A., Camilleri M., Mayer E.A., et al. AGA technical review on irritable bowel syndrome. Gastroenterology 123 (2002) 2108-2131
2. Drossman D.A. The functional gastrointestinal disorders and the Rome III process. In: Drossman D.A., Corazziari E., Delvaux M., et al. (Eds). Rome III: the functional gastrointestinal disorders. 3rd ed. (2006), Degnon Associates, Inc, McLean, VA 1-29
3. Creed F., Levy R., Bradley L., et al. Psychosocial aspects of functional gastrointestinal disorders. In: Drossman D.A., Corazziari E., Delvaux M., et al. (Eds). Rome III: the functional gastrointestinal disorders. 3rd ed. (2006), Degnon Associates, Inc, McLean, VA 295-368
4. Drossman D.A., Toner B.B., Whitehead W.E., et al. Cognitive-behavioral therapy vs. education and desipramine vs. placebo for moderate to severe functional bowel disorders. Gastroenterology 125 (2003) 19-31
5. Jailwala J., Imperiale T.F., and Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med 133 (2000) 136-147
6. Jackson J.L., O'Malley P.G., Tomkins G., et al. Treatment of functional gastrointestinal disorders with anti-depressants: a meta-analysis. Am J Med 108 (2000) 65-72
7. Halpert A., Dalton C.B., Diamant N.E., et al. Clinical response to tricyclic antidepressants in functional bowel disorders is not related to dosage. Am J Gastroenterol 100 (2005) 664-671
8. Sandler R.S., Drossman D.A., Nathan H.P., et al. Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology 87 (1984) 314-318
9. Whitehead W.E., Palsson O., and Jones K.R. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology 122 (2002) 1140-1156
10. Drossman D.A., Whitehead W.E., Toner B.B., et al. What determines severity among patients with painful functional bowel disorders?. Am J Gastroenterol 95 (2000) 974-980
11. Drossman D.A., McKee D.C., Sandler R.S., et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 95 (1988) 701-708
12. Drossman D.A. Brain imaging and its implications for studying centrally targeted treatments in IBS: a primer for gastroenterologists. Gut 54 (2005) 569-573
13. Rollman B.L., Block M.R., and Schulberg H.C. Symptoms of major depression and tricyclic side effects in primary care patients. J Gen Intern Med 12 (1997) 284-291
14. Nelson J.C., Jatlow P.I., and Quinlan D.M. Subjective complaints during desipramine treatment: relative importance of plasma drug concentrations and the severity of depression. Arch Gen Psychiatry 41 (1984) 55-59
15. Asberg M., Cronholm B., Sjoqvist F., et al. Correlation of subjective side effects with plasma concentrations of nortriptyline. Br Med J 4 (1970) 18-21
16. Gerber P.D., Barrett J.E., Barrett J.A., et al. The relationship of presenting physical complaints to depressive symptoms in primary care patients. J Gen Intern Med 7 (1992) 170-173
17. Stoeckle J.D., and Davidson G.E. Bodily complaints and other symptoms of depressive reaction: diagnosis and significance in a medical clinic. JAMA 180 (1962) 134-139
18. Derogatis L.R. SCL-90-R: administration, scoring, and procedures manual II-for the r(evised) version (1983), Clinical Psychometric Research, Towson, MD
19. Chang L., and Drossman D. Psychotropic drugs and management of patients with functional gastrointestinal disorders. Advanced therapy in gastroenterology and liver disease. 5th ed. (2004), BC Decker, Hamilton, ON